Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis

This guideline is an update from August 2020 the S2k-guideline “Atopic dermatitis” published in 2015. The reason for updating this chapter of were current developments field systemic therapy atopic dermatitis. agreed recommendations treatment dermatitis present are based on scientific data. Due to approval dupilumab moderate severe dermatitis, which cannot be treated sufficiently with topical drugs alone, part has now been adapted and newly consented. indication therapeutic response should recorded documented a suitable form clinic practice. A standardized documentation system can recommended also updated guideline.